Chronic conditions and diseases are major causes of disability, ill-health, health-related retirement and premature death, and present considerable social and economic costs. Research in this area continues under Horizon 2020.
Research in the area of 'severe chronic diseases' aims to increase the knowledge of the biological processes and mechanisms involved in normal health and in specific disease situations, and then to bring this knowledge to the clinic to better control and treat the diseases, and to ensure that clinical (including epidemiological) data guide further research.
Elucidation of the causes and mechanisms of the diseases, better and earlier diagnosis and prevention, as well as development of novel therapies, will lead to practical benefits and improve the quality of life of EU citizens.
In the Seventh Framework Programme (FP7 2007-2013) this field of research focuses on non-lethal diseases with a high impact on the quality of life at old age, such as functional and sensory impairment and other chronic diseases (eg. arthritis, rheumatic and musculo-skeletal diseases as well as respiratory diseases including those induced by allergies).
During the first five calls of FP7 funding was awarded to research dealing with hearing impairment in elderly, osteoarthritis, osteoporosis, intervertebral disk degeneration, inflammatory bowel disease, rheumatoid arthritis, chronic obstructive pulmonary disease (COPD), urinary incontinence, age-related muscle weakness, chronic kidney disease and fatty liver disease, as well as to allergy, asthma, and autoimmune diseases. The EU contribution of EUR 132.8 million funded in total 23 projects.